Ignite Creation Date:
2025-12-24 @ 3:25 PM
Ignite Modification Date:
2026-01-16 @ 9:08 AM
Study NCT ID:
NCT04148092
Status:
APPROVED_FOR_MARKETING
Last Update Posted:
2020-05-29
First Post:
2019-10-30
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Expanded Access Program of Ripretinib (DCC-2618) for the Treatment of Patients With Advanced GIST
Sponsor:
Organization: